Procter & Gamble (NYSE:PG - Get Free Report) had its price objective hoisted by equities research analysts at Citigroup from $187.00 to $190.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has a "buy" rating on the stock. Citigroup's price objective would indicate a potential upside of 11.72% from the stock's previous close.
A number of other brokerages also recently issued reports on PG. Evercore upgraded Procter & Gamble from an "in-line" rating to an "outperform" rating and set a $166.00 price objective on the stock in a research report on Tuesday, October 6th. DZ Bank lowered Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, October 27th. Argus cut shares of Procter & Gamble from a "buy" rating to a "hold" rating in a report on Friday, August 7th. Piper Sandler upped their target price on shares of Procter & Gamble from $145.00 to $167.00 and gave the stock a "neutral" rating in a research note on Monday, October 26th. Finally, BNP Paribas Exane raised their price target on Procter & Gamble from $177.00 to $189.00 and gave the stock an "outperform" rating in a research note on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $171.76.
Read Our Latest Stock Report on Procter & Gamble
Procter & Gamble Trading Up 1.3%
NYSE:PG traded up $2.22 on Friday, reaching $170.07. 4,626,184 shares of the stock traded hands, compared to its average volume of 9,725,068. The company has a current ratio of 0.72, a quick ratio of 0.53 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $394.18 billion, a price-to-earnings ratio of 25.65, a price-to-earnings-growth ratio of 4.19 and a beta of 0.36. The company's 50 day moving average is $156.37 and its 200-day moving average is $150.33. Procter & Gamble has a 1-year low of $137.62 and a 1-year high of $173.59.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping analysts' consensus estimates of $1.89 by $0.11. Procter & Gamble had a net margin of 18.23% and a return on equity of 31.02%. The business had revenue of $23.28 billion during the quarter, compared to analysts' expectations of $22.80 billion. During the same period last year, the company posted $1.99 earnings per share. The business's quarterly revenue was up 4.0% on a year-over-year basis. Equities research analysts anticipate that Procter & Gamble will post 6.99 EPS for the current fiscal year.
Insider Buying and Selling
In other Procter & Gamble news, insider Victor Aguilar sold 18,812 shares of the company's stock in a transaction on Friday, October 30th. The stock was sold at an average price of $164.43, for a total value of $3,093,257.16. Following the completion of the sale, the insider directly owned 55,243 shares in the company, valued at $9,083,606.49. This represents a 25.40% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Matthew W. Janzaruk sold 9,479 shares of the firm's stock in a transaction that occurred on Tuesday, November 3rd. The stock was sold at an average price of $163.00, for a total transaction of $1,545,077.00. Following the sale, the chief accounting officer owned 1,271 shares of the company's stock, valued at $207,173. This represents a 88.18% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 193,738 shares of company stock worth $31,813,782 in the last ninety days. Company insiders own 0.23% of the company's stock.
Institutional Trading of Procter & Gamble
Hedge funds have recently added to or reduced their stakes in the company. Stonebrook Private Inc. increased its holdings in Procter & Gamble by 29.8% in the third quarter. Stonebrook Private Inc. now owns 4,485 shares of the company's stock valued at $652,000 after buying an additional 1,030 shares in the last quarter. American Century Companies Inc. grew its stake in shares of Procter & Gamble by 3.6% during the third quarter. American Century Companies Inc. now owns 1,144,952 shares of the company's stock valued at $166,339,000 after acquiring an additional 39,428 shares in the last quarter. PCM Encore LLC raised its stake in Procter & Gamble by 2.9% during the third quarter. PCM Encore LLC now owns 8,942 shares of the company's stock valued at $1,299,000 after buying an additional 255 shares in the last quarter. Defiance ETFs LLC raised its holdings in shares of Procter & Gamble by 9.8% during the third quarter. Defiance ETFs LLC now owns 10,692 shares of the company's stock worth $1,553,000 after purchasing an additional 956 shares during the period. Finally, Kestra Advisory Services LLC grew its holdings in shares of Procter & Gamble by 9.6% during the third quarter. Kestra Advisory Services LLC now owns 620,215 shares of the company's stock valued at $90,105,000 after purchasing an additional 54,539 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Key Headlines Impacting Procter & Gamble
These are some of the PG headlines that stood out recently:
About Procter & Gamble
(
Get Free Report)
The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.